Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Evogene Ltd. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 421.3K | 130.4K | −290.9K (−69.0%) |
| Value | $526.9K | $166.9K | −$360.0K (−68.3%) |
New holders (4)
Institutions that held Evogene Ltd. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 32,017 | $41.0K | 0.00% |
| Citadel Advisors LLC | 21,369 | $27.4K | 0.00% |
| Tradewinds Capital Management, LLC | 300 | $384 | 0.00% |
| Raymond James Financial Inc | 200 | $256 | 0.00% |
Sold out (4)
Institutions that held Evogene Ltd. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Armistice Capital, LLC | 316,024 | $395.0K |
| XTX Topco Ltd | 10,179 | $12.9K |
| JPMorgan Chase & Co | 200 | $114 |
| Tidemark, LLC | 30 | $38 |